Exhibit H-1. Budget Authority by Activity¹

Reflects Planned Re-allocations and Transfers Related to Influenza, Health Information Technology, and Anthrax Antibiotics (Dollars in Thousands)

Program	2004 Actual		2005				2006 Estimate
			Enacted		Revised
	(FTE)	Amount	(FTE)	Amount	(FTE)	Amount	(FTE)	Amount
1. Research on Health Costs, Quality, & Outcomes BA	0	0	0	0	2,520	0		0
PHS Evaluation	[268]	[245,687]	[274]	[260,695]	[277]	[260,695]	[277]	[260,695]
Total Operational Level	268	245,687	274	260,695	277	263,215	277	260,695
2. Medical Expenditure Panel Survey BA	-	0	-	0	-	0	-	0
PHS Evaluation	-	[55,300]	-	[55,300]	-	[55,300]	-	[55,300]
Total Operational Level	-	55,300	-	55,300	-	55,300	-	55,300
3. Program Support BA	-	0	-	0	-	0	-	0
PHS Evaluation	[22]	[2,697]	[22]	[2,700]	[22]	[2,700]	[22]	[2,700]
Total Operational Level	22	2,697	22	2,700	22	2,700	22	2,700
Total, Budget Authority	0	0	0	0	0	2,520		0
Total PHS Evaluation	[290]	[303,684]	[296]	[318,695]	[299]	[318,695]	[299]	[318,695]
Total Operations	290	303,684	296	318,695	299	321,215	299	318,695

¹ Excludes the following amounts for reimbursements:

FY 2004: $29,726,000 ($7,405,000 for NRSAs and $22,321,000 for other reimbursements).
FY 2005: $29,726,000 ($7,405,000 for NRSAs and $22,321,000 for other reimbursements).
FY 2006: $29,726,000 ($7,405,000 for NRSAs and $22,321,000 for other reimbursements).

Return to Exhibits
Proceed to Exhibit H-2